Adaptable High Penetration Prodrug Compositions for Niche Environments

Publication ID: 24-11857545_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptable High Penetration Prodrug Compositions for Niche Environments,” Published Technical Disclosure No. 24-11857545_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857545_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,545.

Summary of the Inventive Concept

The inventive concept adapts high penetration prodrug compositions for specific, narrow markets or unique operational environments, enhancing their effectiveness in treating pulmonary conditions.

Background and Problem Solved

The original patent disclosed high penetration prodrug compositions for treating pulmonary conditions, but these compositions have limitations in high-altitude environments, high-security facilities, disaster relief scenarios, and extreme weather conditions. The new inventive concept addresses these limitations by adapting the prodrug compositions for these specific contexts.

Detailed Description of the Inventive Concept

The inventive concept comprises high penetration prodrug compositions adapted for use in niche environments. For example, the composition may be formulated for delivery in low-oxygen conditions, such as high-altitude environments, or packaged in secure, tamper-evident containers for use in high-security facilities. The composition may also be designed for portable, waterproof storage containers for disaster relief scenarios or wearable, temperature-controlled delivery devices for extreme weather conditions. These adaptations enable more effective treatment of pulmonary conditions in these specialized contexts.

Novelty and Inventive Step

The new inventive concept introduces novel adaptations of high penetration prodrug compositions for specific, narrow markets or unique operational environments. These adaptations are non-obvious and provide a significant improvement over the original patent's compositions, which were not designed for these contexts.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include adapting the prodrug compositions for other niche environments, such as space exploration or high-stress, high-temperature industrial settings. Variations of the composition may also include different formulations or delivery devices tailored to specific environments or applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of pulmonary disease treatment, disaster relief, and high-security medical services. The adapted prodrug compositions may also find applications in niche markets, such as high-altitude tourism or extreme sports.

Field of Art

Pharmaceutical formulations, specifically prodrug compositions for pulmonary condition treatments, with expertise in drug delivery systems, pharmaceutical engineering, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or biomedical engineer with advanced degree, experience in drug formulation, knowledge of prodrug delivery mechanisms, and understanding of environmental adaptation strategies for medical compositions

Obviousness Rationale

A PHOSITA would recognize that adapting high penetration prodrug compositions for specific environmental conditions is a predictable extension of existing pharmaceutical design principles. The source patent establishes a foundational prodrug composition that can be readily modified for specialized delivery contexts. Environmental adaptation represents a standard engineering approach to expanding pharmaceutical utility across different operational scenarios.

Obvious Combinations & Variations

Source Patent Element
Topical pharmaceutical formulation for pulmonary condition treatment
PTD Variation
Adaptation for high-altitude low-oxygen environments
Obviousness Reasoning
Modifying drug penetration characteristics for altitude-related respiratory challenges is a predictable design variation using known pharmaceutical engineering techniques
Source Patent Element
Spray-based topical delivery method
PTD Variation
Secure, tamper-evident delivery system for high-security facilities
Obviousness Reasoning
Implementing additional security features in existing spray delivery mechanisms represents a routine design modification within pharmaceutical packaging engineering
Source Patent Element
Pharmaceutical composition with multiple structural variations
PTD Variation
Portable, waterproof storage containers for disaster relief scenarios
Obviousness Reasoning
Adapting pharmaceutical storage to extreme environmental conditions is a standard approach in medical logistics and represents an obvious extension of existing formulation principles
Source Patent Element
Prodrug composition for respiratory treatments
PTD Variation
Wearable, temperature-controlled delivery device for extreme weather conditions
Obviousness Reasoning
Integrating temperature control mechanisms into drug delivery systems is a known technique for maintaining pharmaceutical stability and efficacy
Source Patent Element
Pharmaceutical screening methodology
PTD Variation
Drug candidate screening in simulated high-stress environments
Obviousness Reasoning
Expanding pharmaceutical screening protocols to include environmental stress testing represents a predictable scientific methodology for evaluating drug performance
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857545, a person having ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure to be obvious extensions of the prior art. The claimed adaptations represent predictable modifications to existing pharmaceutical compositions, employing standard engineering techniques to expand delivery mechanisms and environmental applicability without introducing inventive complexity.

Original Patent Information

Patent NumberUS 11,857,545
TitleHigh penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
Assignee(s)Techfields Pharma Co., Ltd.